CXCL13 expression is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer

Authors:

Abstract
Chemokine (C-X-C motif) ligand 13 (CXCL13/BLC/BCA-1) is a cytokine from C-X-C chemokine family, which is selectively chemotactic for B cells. Previous research has demonstrated that high CXCL13 expression is correlated to poor prognosis in various cancers. However, the association between CXCL13 expression and gastric cancer is still unclear.
Funding Information
  • National Key Projects for Infectious Diseases of China (2012ZX10002012-007, 2016ZX10002018-008)
  • National Natural Science Foundation of China (31100629, 31270863, 81372755, 31470794, 81401988, 81402082, 81402085, 81471621, 81472227, 81472376, 31570803, 81501999, 81671628, 81672324)
  • Program for New Century Excellent Talents in University (NCET-13-0146)

This publication has 33 references indexed in Scilit: